Developing an Algorithm to Convert Routine Measures of Vision into Utility Values for Glaucoma

REFERENCES

• Leske MC. Open-angle glaucoma− an epidemiologic overview. Ophthalmic Epidemiol 2007 Jul-Aug;14(4):166–172.
   PubMed Web of Science ®Google Scholar
• Friedman DS, Wolfs RC, O’Colmain BJ, Klein BE, Taylor HR, West S, et al. Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol. 2004 Apr;122(4):532–538.
   PubMedGoogle Scholar
• Kuper H, Jofre-Bonet M, Gilbert C. Economic evaluation for ophthalmologists. Ophthalmic Epidemiol 2006 Dec;13(6):393–401.
   PubMed Web of Science ®Google Scholar
• Sharma S, Brown GC, Brown MM, Shah GK, Snow K, Brown H, et al. Converting visual acuity to utilities. Can J Ophthalmol 2000 Aug;35(5):267–272.
   PubMed Web of Science ®Google Scholar
• Hopley C, Salkeld G, Wang JJ, Mitchell P. Cost utility of screening and treatment for early age related macular degeneration with zinc and antioxidants. Br J Ophthalmol 2004 Apr;88(4):450–454.
   PubMed Web of Science ®Google Scholar
• Konig HH, Barry JC. Cost effectiveness of treatment for amblyopia: an analysis based on a probabilistic Markov model. Br J Ophthalmol 2004 May;88(5):606–612.
   PubMed Web of Science ®Google Scholar
• Konig HH, Barry JC. Cost-utility analysis of orthoptic screening in kindergarten: a Markov model based on data from Germany. Pediatrics 2004 Feb;113(2):95–108.
   PubMed Web of Science ®Google Scholar
• Nordmann JP, Lafuma A, Deschaseaux C, Berdeaux G. Clinical outcomes of glaucoma treatments over a patient lifetime− a Markov model. J Glaucoma 2005 Dec;14(6):463–469.
   PubMed Web of Science ®Google Scholar
• Sharma S, Brown GC, Brown MM, Hollands H, Shah GK. The cost-effectiveness of photodynamic therapy for fellow eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. Ophthalmology 2001 Nov;108(11):2051–2059.
   PubMed Web of Science ®Google Scholar
• Bansback N, Czoski-Murray C, Carlton J, Lewis G, Hughes L, Espallargues M, et al. Determinants of health related quality of life and health state utility in patients with age related macular degeneration: the association of contrast sensitivity and visual acuity. Qual Life Res 2007 Apr;16(3):533–543.
   PubMed Web of Science ®Google Scholar
• Bansback N, Davis S, Brazier J. Using contrast sensitivity to estimate the cost-effectiveness of verteporfin in patients with predominantly classic age-related macular degeneration. Eye 2007 Dec;21(12):1455–1463.
   PubMed Web of Science ®Google Scholar
• Bowers A, Peli E, Elgin J, McGwin G, Owsley C. On-road driving with moderate visual field loss. Optometry Vision Sci 2005 Aug;82(8):657–667.
   PubMed Web of Science ®Google Scholar
• Hawkins AS, Szlyk JP, Ardickas Z, Alexander KR, Wilensky JT. Comparison of contrast sensitivity, visual acuity, and Humphrey Visual Field testing in patients with glaucoma. J Glaucoma 2003 Apr;12(2):134–138.
   PubMed Web of Science ®Google Scholar
• Nelson P, Aspinall P, Papasouliotis O, Worton B, O’Brien C. Quality of life in glaucoma and its relationship with visual function. J Glaucoma 2003 Apr;12(2):139–150.
   PubMed Web of Science ®Google Scholar
• Spaeth G, Walt J, Keener J. Evaluation of quality of life for patients with glaucoma. Am J Ophthalmol 2006 Jan;141(1):S3–S14.
   Web of Science ®Google Scholar
• Viswanathan AC, McNaught AI, Poinoosawmy D, Fontana L, Crabb DP, Fitzke FW, et al. Severity and stability of glaucoma: patient perception compared with objective measurement. Arch Ophthalmol 1999 Apr;117(4):450–454.
   PubMedGoogle Scholar
• Rein DB, Wirth KE, Johnson CA, Lee PP. Estimating quality-adjusted life year losses associated with visual field deficits using methodological approaches. Ophthalmic Epidemiol 2007 Jul–Aug;14(4):258–264.
   PubMed Web of Science ®Google Scholar
• Gupta V, Srinivasan G, Mei SS, Gazzard G, Sihota R, Kapoor KS. Utility values among glaucoma patients: an impact on the quality of life. Br J Ophthalmol 2005 Oct;89(10):1241–1244.
   PubMed Web of Science ®Google Scholar
• Jampel HD, Friedman DS, Quigley H, Miller R. Correlation of the binocular visual field with patient assessment of vision. Invest Ophthalmol Vis Sci 2002 Apr;43(4):1059–1067.
   PubMed Web of Science ®Google Scholar
• Jampel HD, Schwartz A, Pollack I, Abrams D, Weiss H, Miller R. Glaucoma patients’ assessment of their visual function and quality of life. J Glaucoma 2002 Apr;11(2):154–163.
   PubMed Web of Science ®Google Scholar
• Saw SM, Gazzard G, Eong KGA, Oen F, Seah S. Utility values in Singapore Chinese adults with primary open-angle and primary angle-closure glaucoma. J Glaucoma 2005 Dec;14(6):455–462.
   PubMed Web of Science ®Google Scholar
• Aspinall P, Hill AR, Nelson P, O’Brien C, O’Connell E, McCloughan L, et al. Quality of life in patients with glaucoma: a conjoint analysis approach visual impairment research. 2005;7:13–26
   Google Scholar
• Kobelt G, Jonsson B, Bergstrom A, Chen E, Linden C, Alm A. Cost-effectiveness analysis in glaucoma: what drives utility? Results from a pilot study in Sweden. Acta Ophthalmol Scand 2006 Jun;84(3):363–371.
   PubMedGoogle Scholar
• Burr JM, Kilonzo M, Vale L, Ryan M. Developing a preference-based glaucoma utility index using a discrete choice experiment. Optom Vis Sci 2007 Aug;84(8):797–808.
   PubMed Web of Science ®Google Scholar
• Aspinall PA, Johnson ZK, Azuara-Blanco A, Montarzino A, Brice R, Vickers A. Evaluation of quality of life and priorities of patients with glaucoma. Invest Ophthalmol Vis Sci 2008 May;49(5):1907–1915.
   PubMed Web of Science ®Google Scholar
• Sun X, Zhang S, Wang N, Liang Y, Wang L, Fan S, et al. Utility assessment among patients of primary angle closure glaucoma in China: a preliminary study. Br J Ophthalmol 2009 Jul;93(7):871–874.
   PubMed Web of Science ®Google Scholar
• Crabb DP, Viswanathan AC. Integrated visual fields: a new approach to measuring the binocular field of view and visual disability. Graefes Arch Clin Exp Ophthalmol 2005 Mar;243(3):210–216.
   PubMed Web of Science ®Google Scholar
• Recommended standard procedures for the clinical measurement,and specification of visual acuity. Report of working group 39. Committee on vision. Assembly of Behavioral and Social Sciences, National Research Council, National Academy of Sciences, Washington, DC. Adv Ophthalmol 1980;41:103–148.
   PubMedGoogle Scholar
• Bailey IL, Lovie JE. New design principles for visual acuity letter charts. Am J Optom Physiol Opt 1976 Nov;53(11):740–745.
   PubMedGoogle Scholar
• Ferris FL, Kassoff A, Bresnick GH, Bailey I. New visual-acuity charts for clinical research. Am J Ophthalmol 1982;94(1):91–6.
   PubMed Web of Science ®Google Scholar
• Schulze-Bonsel K, Feltgen N, Burau H, Hansen L, Bach M. Visual acuities “hand motion” and “counting fingers” can be quantified with the Freiburg visual acuity test. Invest Ophthalmol Vis Sci 2006 Mar;47(3):1236–1240.
   PubMed Web of Science ®Google Scholar
• Pelli DG, Robson JG, Wilkins AJ. The design of a new letter chart for measuring contrast sensitivity. Clin Vis Sci 1988;2(3):187–199.
   Google Scholar
• Birt CM, Shin DH, Samudrala V, Hughes BA, Kim C, Lee D. Analysis of reliability indices from Humphrey visual field tests in an urban glaucoma population. Ophthalmology 1997 Jul;104(7):1126–1130.
   PubMed Web of Science ®Google Scholar
• Office for National Statistics. Chapter 14: Deriving NS-SEC: Self-coded method. In: The national statistics socio-economic classification: user manual. Office for National Statistics, 2005.
   Google Scholar
• Brown GC, Brown MM, Sharma S, Beauchamp G, Hollands H. The reproducibility of ophthalmic utility values. Trans Am Ophthalmol Soc 2001;99:199–203.
   PubMedGoogle Scholar
• Brown MM, Brown GC, Sharma S, Landy J. Health care economic analyses and value-based medicine. Surv Ophthalmol 2003 Mar–Apr;48(2):204–223.
   PubMed Web of Science ®Google Scholar
• Hollands H, Lam M, Pater J, Albiani D, Brown GC, Brown M, et al. Reliability of the time trade-off technique of utility assessment in patients with retinal disease. Can J Ophthalmol–J Can D Ophtalmologie 2001 Jun;36(4):202–209.
   PubMed Web of Science ®Google Scholar
• Brown GC, Sharma S, Brown MM, Kistler J. Utility values and age-related macular degeneration. Arch Ophthalmol 2000 Jan;118(1):47–51.
   PubMedGoogle Scholar
• Brown MM, Brown GC, Sharma S, Shah G. Utility values and diabetic retinopathy. Am J Ophthalmol 1999 Sep;128(3):324–330.
   PubMed Web of Science ®Google Scholar
• Schiffman RM, Walt JG, Jacobsen G, Doyle JJ, Lebovics G, Sumner W. Utility assessment among patients with dry eye disease. Ophthalmology 2003 Jul;110(7):1412–1419.
   PubMed Web of Science ®Google Scholar
• Membreno JH, Brown MM, Brown GC, Sharma S, Beauchamp GR. A cost-utility analysis of therapy for amblyopia. Ophthalmology 2002 Dec;109(12):2265–2271.
   PubMed Web of Science ®Google Scholar
• Sharma S, Brown GC, Brown MM, Hollands H, Robins R, Shah GK. Validity of the time trade-off and standard gamble methods of utility assessment in retinal patients. Br J Ophthalmol 2002 May;86(5):493–496.
   PubMed Web of Science ®Google Scholar
• Brown GC. Vision and quality-of-life. Trans Am Ophthalmol Soc 1999;97:473–511.
   PubMedGoogle Scholar
• Brown MM, Brown GC, Sharma S, Busbee B. Quality of life associated with visual loss: a time tradeoff utility analysis comparison with medical health states. Ophthalmology 2003 Jun;110(6):1076–1081.
   PubMed Web of Science ®Google Scholar
• Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001 Jul;33(5):337–343.
   PubMed Web of Science ®Google Scholar
• Jenkinson C, Stewart-Brown S, Petersen S, Paice C. Assessment of the SF-36 version 2 in the United Kingdom. J Epidemiol Comm Health 1999 Jan;53(1):46–50.
   PubMed Web of Science ®Google Scholar
• Ware JE, Kosinski M, Dewey JE. Chapter 8: Norms U.S. Population. In: How to Score Version 2 of the SF-36 Health Survey. Lincoln: QualityMetric Incorporated; 2000:65–66.
   Google Scholar
• Hart PM, Chakravarthy U, Stevenson MR, Jamison JQ. A vision specific functional index for use in patients with age related macular degeneration. Br J Ophthalmol 1999 Oct;83(10):1115–1120.
   PubMed Web of Science ®Google Scholar
• Hart PM, Stevenson MR, Montgomery AM, Muldrew KA, Chakravarthy U. Further validation of the Daily Living Tasks Dependent on Vision: identification of domains. Br J Ophthalmol 2005 Sep;89(9):1127–1130.
   PubMed Web of Science ®Google Scholar
• Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol 2001 Jul;119(7):1050–1058.
   PubMedGoogle Scholar
• Mangione CM, Lee PP, Pitts J, Gutierrez P, Berry S, Hays RD. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators. Arch Ophthalmol 1998 Nov;116(11):1496–1504.
   PubMedGoogle Scholar
• RAND website, accessed March 27, 2007 from: http://www.rand.org/health/surveys_tools/depression/index.html
   Google Scholar
• UCLA Academic Technology Services website, accessed May 15, 2007 from: http://www.ats.ucla.edu/stat/stata/dae/tobit.htm
   Google Scholar
• Murphy CC, Hughes EH, Frost NA, Dick AD. Quality of life and visual function in patients with intermediate uveitis. Br J Ophthalmol 2005 Sep;89(9):1161–1165.
   PubMed Web of Science ®Google Scholar
• Green J, Siddall H, Murdoch I. Learning to live with glaucoma: a qualitative study of diagnosis and the impact of sight loss. Soc Sci Med 2002 Jul;55(2):257–267.
   PubMed Web of Science ®Google Scholar
• Brown MM, Brown GC, Sharma S, Hollands H, Landy J. Quality of life and systemic comorbidities in patients with ophthalmic disease. Br J Ophthalmol 2002 Jan;86(1):8–11.
   PubMed Web of Science ®Google Scholar
• Real FJ, Brown GC, Brown HC, Brown MM. The effect of comorbidities upon ocular and systemic health-related quality of life. Br J Ophthalmol 2008 Jun;92(6):770–774.
   PubMed Web of Science ®Google Scholar
• Revicki DA, Kaplan RM. Relationship between psychometric and utility-based approaches to the measurement of health-related quality-of-life. Quality Life Res 1993 Dec;2(6):477–487.
   PubMed Web of Science ®Google Scholar
• Buxton MJ, Lacey LA, Feagan BG, Niecko T, Miller DW, Townsend RJ. Mapping from disease-specific measures to utility: an analysis of the relationships between the Inflammatory Bowel Disease Questionnaire and Crohn’s Disease Activity Index in Crohn’s disease and measures of utility. Value Health 2007 May–Jun;10(3):214–220.
   PubMed Web of Science ®Google Scholar
• Dobrez D, Cella D, Pickard AS, Lai JS, Nickolov A. Estimation of patient preference-based utility weights from the functional assessment of cancer therapy− general. Value Health 2007 Jul–Aug;10(4):266–272.
   PubMed Web of Science ®Google Scholar
• Grootendorst P, Marshall D, Pericak D, Bellamy N, Feeny D, Torrance GW. A model to estimate health utilities index mark 3 utility scores from WOMAC index scores in patients with osteoarthritis of the knee. J Rheumatol 2007 Mar;34(3):534–542.
   PubMed Web of Science ®Google Scholar
• Ringsdorf L, McGwin G, Jr., Owsley C. Visual field defects and vision-specific health-related quality of life in African Americans and whites with glaucoma. J Glaucoma 2006 Oct;15(5):414–418.
   PubMed Web of Science ®Google Scholar
• Arnesen T, Trommald M. Are QALYs based on time trade-off comparable? A systematic review of TTO methodologies. Health Econ 2005 Jan;14(1):39–53.
   PubMed Web of Science ®Google Scholar
• Dolan P, Roberts J. To what extent can we explain time trade-off values from other information about respondents? Soc Sci Med 2002 Mar;54(6):919–929.
   PubMed Web of Science ®Google Scholar
• Baker R, Robinson A. Responses to standard gambles: are preferences ‘well constructed’? Health Econ 2004 Jan;13(1):37–48.
   PubMed Web of Science ®Google Scholar
• Lenert L, Kaplan RM. Validity and interpretation of preference-based measures of health-related quality of life. Med Care 2000 Sep;38(9 Suppl):II138–50.
   PubMed Web of Science ®Google Scholar
• Torrance GW. Utility measurement in healthcare: the things I never got to. Pharmacoeconomics 2006;24(11):1069–1078.
   PubMed Web of Science ®Google Scholar
• Haymes SA, Leblanc RP, Nicolela MT, Chiasson LA, Chauhan BC. Risk of falls and motor vehicle collisions in glaucoma. Invest Ophthalmol Vis Sci 2007 Mar;48(3):1149–1155.
   PubMed Web of Science ®Google Scholar
• Torrance GW, Thomas WH, Sackett DL. A utility maximization model for evaluation of health care programs. Health Serv Res 1972 Summer;7(2):118–133.
   PubMedGoogle Scholar
• Janz NK, Wren PA, Guire KE, Musch DC, Gillespie BW, Lichter PR. Fear of blindness in the Collaborative Initial Glaucoma Treatment Study patterns and correlates over time. Ophthalmology 2007 May 8; In press.
   PubMed Web of Science ®Google Scholar
• Inskew question. Accessed August 12, 2010 from: http://www.stata.com/statalist/archive/2002-12/msg00193.html. 2002
   Google Scholar
• Manning WG, Morris CN, Newhouse JP, Orr LL, Duan N, Keeler EB. A two-part model of the demand for medical care: preliminary results from the Health Insurance Study. In: van der Gaag J, Perlman M, editors. Health, economics and health economics. Amsterdam: North Holland Publishing Company; 1981.
   Google Scholar
• Lee BS, Kymes SM, Nease RF, Jr., Sumner W, Siegfried CJ, Gordon MO. The impact of anchor point on utilities for 5 common ophthalmic diseases. Ophthalmology 2008 May;115(5):898–903 e4.
   PubMed Web of Science ®Google Scholar
• Kymes SM, Lee BS. Preference-based quality of life measures in people with visual impairment. Optom Vis Sci 2007 Aug;84(8):809–816.
   PubMed Web of Science ®Google Scholar
• Excellence NICE. Guide to the methods of technology appraisal. London: National Institute for Clinical Excellence; April 2004.
   Google Scholar
• Brazier J. Valuing health states for use in cost-effectiveness analysis. Pharmacoeconomics 2008;26(9):769–779.
   PubMed Web of Science ®Google Scholar
• Stiggelbout AM, de Vogel-Voogt E. Health state utilities: a framework for studying the gap between the imagined and the real. Value Health 2008 Jan–Feb;11(1):76–87.
   PubMed Web of Science ®Google Scholar